**Core Concept**
Ticlodipine is an antiplatelet medication used to prevent stroke and other cardiovascular events. It belongs to the class of thienopyridines, which inhibit platelet activation and aggregation by irreversibly blocking the P2Y12 receptor.

**Why the Correct Answer is Right**
Ticlodipine works by blocking the P2Y12 receptor on platelet membranes, which is a crucial step in the platelet activation cascade. By inhibiting the P2Y12 receptor, ticlodipine reduces the formation of thromboxane A2, a potent platelet aggregator. This action results in a significant reduction in the risk of arterial thrombosis and stroke.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because ticlodipine is not a direct vasodilator. While it does reduce blood pressure by reducing platelet aggregation, its primary mechanism is not through vasodilation.
**Option B:** This option is incorrect because ticlodipine is not an anticoagulant. It does not work by inhibiting the coagulation cascade, but rather by blocking platelet activation and aggregation.

**Clinical Pearl / High-Yield Fact**
Ticlodipine has a long half-life and can accumulate in patients with renal impairment, increasing the risk of bleeding complications. This highlights the importance of monitoring renal function and adjusting doses accordingly in patients taking ticlodipine.

**Correct Answer:**
(Note: Since the options are missing, I'll provide a generic response. Please replace with actual options.)
Correct Answer: A.